2-aminopyridine analogs as glucokinase activators
US8362037B2 · kind B2 · utility
2Cited by
4References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2008 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Jun 25, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes mellitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.